CSF3 and infection: (67) reported lower transplant-related mortality, lower cumulative mortality, lower invasive fungal disease mortality, and lower infection-related mortality in prophylactic molgramostim-containing regimens compared to granulocyte colony-stimulating factor (G-CSF).